Another newly published market research titledRelapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Relapsed Acute Myeloid Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

He and his coinvestigators used data from the Surveillance, Epidemiology, and End Results 9 (SEER 9) cancer registry to establish a prospective cohort for which complete treatment and acute myeloid leukemia incidence data were available.

The study led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center validates certain activating mutations in the FLT3 gene as targets for acute myeloid leukemia therapy-a critically important finding for developing drugs.

For example, a new diagnosis of acute myeloid leukemia lacking expression of CD34 and HLA-DR raises the possibility of an acute promyelocytic leukemia and would prompt careful morphologic review, consideration of cytogenetic fluorescence in situ hybridization (FISH) for the t(15;17); PML-RARA, and clinical evaluation of the patient for evidence of disseminated intravascular coagulation.

Nevertheless, physician Simone Boehrer of the Gustave-Roussy Institute in Villejuif, France, and her colleagues tested erlotinib in a lab dish on bone marrow cells taken from 10 patients with either acute myeloid leukemia or a precancerous blood disorder called myelodysplastic syndrome.

We conducted a retrospective review of pathology files and hospital records and identified three unusual presentations of granulocytic sarcoma associated with acute myeloid leukemia (AML) of the head and neck.

Korte and colleagues from the University of North Carolina at Chapel Hill compared published epidemiological data to their own risk assessment predictions to determine the proportion of all types of leukemia and acute myeloid leukemia (AML) attributable to benzene in cigarette smoke [EHP 108:333-339].

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.